- Home
- About us
- Products
- Bioreactors and Fermentors Cell Culture Fermenter Fermentor Bioreactor
- Other Bioprocess Equipment Automatic Fermenter Bioreactor 100l Fermenter bacteria Bioreactor
- Mammalian Cell Bioreactor 200l Bioreactor Stainless Steel Bioreactor bioreactor Fermenter
- Lab Fermenter Bioreactor Industrial Stainless Steel Fermenter
- Vaccine Fermenter(GMP) Fermentation Equipment stainless Steel Bioreactor
- Mini Lab Glass Fermenter Magnetic Mixing Cell Culture Fermenter Bioreactor
- CIP Station Automatic Bioreactor Fermenter
- Faqs
- News
- Certificate
- Contact us
UK House of Lords: UK needs to take urgent action to embrace synthetic biology, otherwise it will lose significant economic and industrial benefits!
time2025/01/17
- Recently, a report from the UK House of Lords Science and Technology Committee warned that the UK needs to take "urgent" action to embrace synthetic biology, otherwise there is a risk of losing economic and industrial benefits.
The committee emphasized that although the UK was a world leader in synthetic biology 10 years ago, this position has now declined as other countries invest more time and money in the field.
To address this issue, the committee emphasized seven policy areas that the UK needs to focus on - strategy, skills, regulation, infrastructure, investment, adoption, and governance - in order to leverage synthetic biology and make it thrive.
Synthetic biology involves designing and constructing new or modified organisms or molecules based on those found in nature.
The current applications include using engineering bacteria to convert waste into fuel, producing synthetic meat, and utilizing microorganisms to recover and recycle rare earth minerals.
Suddenly! Two party lawmakers in the United States: restrict exports of American biotechnology to China!
The specific policy recommendations of the UK House of Lords Technology Committee in terms of strategy: The government should incorporate synthetic biology into the industrial strategy, formulate detailed plans, clarify development goals and directions.
such as building a broad and rich synthetic biology ecosystem, seizing opportunities brought by synthetic biology, commercializing and applying it to maintain safety and improve disaster response capabilities.
In terms of skills: expand the training scale in the UK, attract top talents from abroad, utilize the existing doctoral training centers of the UK Research and Innovation Agency, and strengthen doctoral training in the field of synthetic biology;
Through intergovernmental contacts and broader science, trade, and technology diplomacy, deepen understanding of the global skills market, and share and complement skills and knowledge foundations with international partners.
Regulatory aspect: Improve the regulatory system for synthetic biology, provide industry training and seek cooperation opportunities for regulatory agencies through the newly established network of synthetic biology regulatory agencies in 2023;
Establish 3-5 'regulatory sandboxes' to conduct evidence-based analysis of product quality and safety, providing a basis for developing regulatory regulations that are trusted by the public.
In terms of infrastructure, explore public and private funding models to improve the accessibility of infrastructure; Based on the professional expertise of academic and industrial clusters in the UK, as well as the distribution of local raw materials, establish future infrastructure that is suitable for them;
Track the progress of global synthetic biology infrastructure, support UK stakeholders in establishing overseas partnerships, and acquire overseas capabilities and expertise.
In terms of investment: providing sustained and stable financial support, such as the UK government launching the "Artificial Intelligence Life Science Accelerator Mission" in 2023, with a total investment of £ 100 million;
Investing £ 2 billion in the field of synthetic biology over the next decade; Ensure that government export control regulatory agencies have sufficient understanding of synthetic biology and avoid excessive regulation that hinders investment.
What is GMP equipment? What are the common GMP equipment?
Application: To cultivate investors and customers who fully understand the potential of synthetic biology, as well as enterprises that understand the concerns of potential customers, so that enterprises can develop popular products and processes in the design stage and successfully attract commercial investment;
Organize an exhibition to highlight the leading companies and innovations in the field of synthetic biology in the UK, and promote dialogue throughout the entire synthetic biology value chain.
In terms of governance, promote active, transparent, and constructive dialogue between the UK government, business, academia, and the public to raise awareness of the potential and risks of synthetic biology;
The UK should leverage its influence in the multilateral system to establish international norms and standards, play an active role in international organizations, and provide technical evidence for policy recommendations related to the development of synthetic biology worldwide.
